Pages Menu
Categories Menu

Posted by on Jan 15, 2015 in Foundation NewsLine |

Orphazyme Clinical Trial Updates ~ Press Releases

Dear NNPDF Families and Friends, 
RE: Orphazyme ~ “Orphazyme ApS ( was founded in June 2009 with the aim of developing heat shock protein based therapy for the treatment of diseases caused by defects in the function and/or metabolism of proteins.”
The NNPDF is making press release announcements from Orphazyme, pertaining to their advances towards a clinical trial for Niemann-Pick Disease type C, available to the wider NPC Community. For a full archive of Orphazyme updates, visit the NNPDF Orphazyme web page.
Visit this link to the Orphazyme APS (LLC) website to read the press releases:
“The National Niemann-Pick Disease Foundation (NNPDF) does not engage in the practice of medicine. It is not a medical authority nor does it claim to have medical knowledge. This site is an educational service of the National Niemann-Pick Disease Foundation and is not meant to provide diagnostic or treatment advice. Information contained or suggested on this Web site does not constitute medical advice. For all information related to care, medication or treatment, the NNPDF recommends consulting a physician to determine if information presented is applicable. Please review these additional cautions about medical information provided on the Internet.”
Share this!

Please spread the word!